The impact of smoking and quitting smoking on patients with diabetes

Diabetes Spectrum

Volumn 18, Issue 4, 2005, Pages 202-208

  Sherman, Justin J ^a,b  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b VA Outpatient Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CANNABINOID RECEPTOR ANTAGONIST; LIPID; NICOTINE; NICOTINE GUM; NORTRIPTYLINE; RIMONABANT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DEPRESSION; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; GASTROINTESTINAL SYMPTOM; HEARTBURN; HICCUP; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MORTALITY; NAUSEA; NICOTINE REPLACEMENT THERAPY; OUTCOMES RESEARCH; REVIEW; RISK FACTOR; SMOKING; SMOKING CESSATION; UNITED STATES; WEIGHT GAIN;

EID: 27844472860     PISSN: 10409165     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaspect.18.4.202     Document Type: Review

References (31)

1. U.-S. Department of Health and Human Services: Healthy People 2000: Midcourse Review and 1995 Revisions. Washington, D.C., U.S. Department of Health and Human Services, Public Health Service, 1995
2. Ford E, Malarcher A, Herman W, Aubert R: Diabetes mellitus and cigarette smoking: findings from the 1989 National Health Interview Survey. Diabetes Care 17:688-692, 1994
3. Solberg L, Desai J, O'Connor P, Bishop D, Devlin H: Diabetic patients who smoke: are they different? Ann Fam Med 2:26-32, 2004
4. Haire-Joshu D, Glasgow RE, Tibbs TL: Smoking and diabetes (Technical Review). Diabetes Care 22:1887-1898, 1999
5. Ikeda Y, Suehiro T, Takamatsu K, Yamashita H, Tamura T, Hashimoto K: Effect of smoking on the prevalence of albuminuria in Japanese men with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 36:57-61, 1997
6. Sands M, Shetterly S, Franklin G, Hamman R: Incidence of distal symmetric neuropathy in MDDM: the San Luis Diabetes Study. Diabetes Care 20:322-329, 1997
7. Prochaska A: New developments in smoking cessation. Chest 117 (Suppl. 4):169S-175S, 2000
8. Ruggiero L, Rossi J, Prochaska J, Glasgow R, de Groot M, Dryfoos J, Reed G, Orleans C, Prokhorov A, Kelly K: Smoking and diabetes: readiness for change and provider advice. Addict Behav 24:573-578, 1999
9. Simon JA, Carmody TP, Hudes ES, Snyder E, Murray J: Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers treated with transdermal nicotine replacement: a randomized trial. Am J Med 114:555-562, 2003
10. Haire-Joshu D, Heady S, Thomas L, Schechtman K, Fisher EB Jr: Beliefs about smoking and diabetes care. Diabetes Educ 20:410-415, 1994
11. Everson SA, Goldberg DE, Helmrich SP, Lakka TA, Lynch JW, Kaplan GA, Salonen JT: Weight gain and the risk of developing insulin resistance syndrome. Diabetes Care 21:1637-1643, 1998
12. Flegal KM, Troiano RP, Pamuk ER, Kuczmarski RJ, Campbell SM: The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med 333:1165-1170, 1995
13. Wannamethee SG, Shaper AG, Perry IJ: Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care 24:1590-1595, 2001
14. Rimm EB, Manson JE, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Hennekens CH, Speizer FE: Cigarette smoking and the risk of diabetes in women. Am J Public Health 83:211-214, 1993
15. Chaturvedi N, Stevens L, Fuller JH: Which features of smoking determine mortality risk in former cigarette smokers with diabetes? The World Health Organization Multinational Study Group. Diabetes Care 20:1266-1272, 1997
16. Gavard JA, Lustman PJ, Clouse RE: Prevalence of depression in adults with diabetes. Diabetes Care 16:1167-1178, 1993
17. Katon W, Von Korff M, Ciechanowski P, Russo J, Lin E, Simon G, Ludman E, Walker E, Bush T, Young B: Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 27:914-920, 2004
18. Haire-Joshu D, Heady S, Thomas L, Schechtman K, Fisher EB Jr: Depressive symptomatology and smoking among persons with diabetes. Res Nurs Health 17:273-282, 1994
19. Targher G, Alberiche M, Zenere MB, Bonadonna RC, Muggeo M, Bonora E: Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82:3619-3624, 1997
20. Reaven G, Tsao PS: Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? J Am Coll Cardiol 41:1044-1047, 2003
21. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB: A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340:685-691, 1999
22. Boyd ST, Fremming BA: Rimonabant-a selective CB1 antagonist. Ann Pharmacother 39:684-690, 2005
23. Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365:1363-1364, 2005
24. Fagerstrom KO: Combined use of nicotine replacement products. Health Values 18:15-20, 1994
25. Okuyemi KS, Ahluwalia JS, Harris KJ. Pharmacotherapy of smoking cessation. Arch Fam Med 9:270-281, 2000
26. U.-K. Prospective Diabetes Study Group: Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
27. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20:614-620, 1997
28. O'Conner PJ, Spencer E, Woolf SH: Care of adults with type 2 diabetes mellitus: a review of the evidence. J Fam Pract 47 (Suppl. 5):S13-S22, 1998
29. Savage PJ, Narayan KMV: Reducing cardiovascular complications of type 2 diabetes: a complex but achievable and affordable task. Diabetes Care 22:1769-1770, 1999
30. Egede LE, Zheng D: Modifiable cardiovascular risk factors in adults with diabetes: prevalence and missed opportunities for physician counseling. Arch Intern Med 162:427-433, 2002
31. Boyle R, Solberg LI: Is making smoking status a vital sign sufficient to increase cessation support actions in clinical practice? Ann Fam Med 2:22-25, 2004